Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicountry, Multicenter, Retrospective Study Evaluating the Patient Characteristics, Disease Burden, Treatment Patterns, and Patient Journey of Advanced Epithelial Ovarian Cancer Patients: A Korean, Taiwanese, and Australian Secondary Database Study

NCT04460768 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04460768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04460768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicountry, Multicenter, Retrospective Study Evaluating the Patient Characteristics, Disease Burden, Treatment Patterns, and Patient Journey of Advanced Epithelial Ovarian Cancer Patients: A Korean, Taiwanese, and Australian Secondary Database Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 27, 2020
Completion date
November 10, 2020
Enrollment
989 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasms